Feline polynucleotide vaccine formula

Details for Australian Patent Application No. 2008203549 (hide)

Owner Merial Ltd

Inventors Baudu, Philippe; Bouchardon, Annabelle; Riviere, Michel; Audonnet, JeanChristophe

Agent FB Rice

Pub. Number AU-A-2008203549

Parent 2004205140

Filing date 8 August 2008

Wipo publication date 28 August 2008

International Classifications

C12N 15/48 (2006.01) Mutation or genetic engineering

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

C12N 15/35 (2006.01) Mutation or genetic engineering

C12N 15/38 (2006.01) Mutation or genetic engineering

C12N 15/40 (2006.01) Mutation or genetic engineering - Proteins from RNA viruses, e.g. flaviviruses

C12N 15/47 (2006.01) Mutation or genetic engineering

C12N 15/49 (2006.01) Mutation or genetic engineering

C12N 15/50 (2006.01) Mutation or genetic engineering

Event Publications

21 August 2008 Complete Application Filed

28 August 2008 Application Open to Public Inspection

  Published as AU-A-2008203549

26 March 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008203550-Process for producing (R)-3-hydroxy-3-(2-phenylethyl)hexanoi c acid and its intermediate

2008203548-Apparatus and methods for producing and using high-density cells and products therefrom